21 May 2013
Keywords: arrow, hcv, drug, enters, ph, uk, trial
Article | 04 December 2006
Arrow Therapeutics, a London, UK-based antiviral drug discovery and development company, has initiated a Phase I study of A-831, its
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 December 2006
27 November 2006
20 May 2013
© 2013 thepharmaletter.com